CompletedNCT04014764
Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy
Studying Acute lymphoblastic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Notable Labs
- Principal Investigator
- Hiroomi Tada, MD, Ph.D.Notable Labs
- Intervention
- This is a non-interventional study(other)
- Enrollment
- 119 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2022
Study locations (20)
- CBCC Global Research, Bakersfield, California, United States
- Pacific Central Coast Health Centers -- SLO Oncology and Hematology Health Center, San Luis Obispo, California, United States
- Colorado West Healthcare System, dba Grand Valley Oncology, Grand Junction, Colorado, United States
- Ocala Oncology Center, Ocala, Florida, United States
- Mid Florida Hematology and Oncology Center, Orange City, Florida, United States
- Touro Infirmary, New Orleans, Louisiana, United States
- Northern Light Cancer Care Center, Brewer, Maine, United States
- New York Cancer and Blood Specialists, Port Jefferson Station, New York, United States
- East Carolina University, Greenville, North Carolina, United States
- The Lindner Center for Research and Education at The Christ Hospital -- The Cancer Center, Cincinnati, Ohio, United States
- Utah Cancer Specialists, Salt Lake City, Utah, United States
- University Hospital of Alexandroupolis, Alexandroupoli, Greece
- National Kapodistrian University of Athens, Athens, Greece
- Attikon University Hospital, Athens, Greece
- National Kapodistrian Hospital/Laikon General Hospital, Athens, Greece
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04014764 on ClinicalTrials.govOther trials for Acute lymphoblastic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05621291A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...National Cancer Institute (NCI)
- RECRUITINGPHASE2NCT07328503CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)
- ENROLLING BY INVITATIONNCT07511959Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative DentistryWroclaw Medical University
- RECRUITINGPHASE2NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaUniversity of Washington
- RECRUITINGNANCT07191119Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT07275762Y-4 to Treat the Postherpetic NeuralgiaNeurodawn Pharmaceutical Co., Ltd.
- RECRUITINGNANCT07177183Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning FailureUniversity Hospital Ostrava
- ENROLLING BY INVITATIONNCT07515430The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic LeukemiaSun Yat-sen University